DK0831797T3 - Farmaceutisk aktive carotenoider - Google Patents

Farmaceutisk aktive carotenoider

Info

Publication number
DK0831797T3
DK0831797T3 DK96916256T DK96916256T DK0831797T3 DK 0831797 T3 DK0831797 T3 DK 0831797T3 DK 96916256 T DK96916256 T DK 96916256T DK 96916256 T DK96916256 T DK 96916256T DK 0831797 T3 DK0831797 T3 DK 0831797T3
Authority
DK
Denmark
Prior art keywords
carotenoids
pharmaceutically active
zeaxanthin
lutein
active carotenoids
Prior art date
Application number
DK96916256T
Other languages
Danish (da)
English (en)
Inventor
Alan Norman Howard
John Thomas Landrum
Richard Andrew Bone
Original Assignee
Howard Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9604221.3A external-priority patent/GB9604221D0/en
Application filed by Howard Foundation filed Critical Howard Foundation
Application granted granted Critical
Publication of DK0831797T3 publication Critical patent/DK0831797T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK96916256T 1995-06-07 1996-06-07 Farmaceutisk aktive carotenoider DK0831797T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48762795A 1995-06-07 1995-06-07
GBGB9604221.3A GB9604221D0 (en) 1995-06-07 1996-02-28 Pharmaceutically active carotenoids
PCT/GB1996/001368 WO1996040092A1 (en) 1995-06-07 1996-06-07 Pharmaceutically active carotenoids

Publications (1)

Publication Number Publication Date
DK0831797T3 true DK0831797T3 (da) 2007-04-02

Family

ID=26308821

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96916256T DK0831797T3 (da) 1995-06-07 1996-06-07 Farmaceutisk aktive carotenoider

Country Status (10)

Country Link
EP (1) EP0831797B1 (de)
AT (1) ATE355832T1 (de)
AU (1) AU719671B2 (de)
CA (1) CA2224217C (de)
DE (1) DE69636951T2 (de)
DK (1) DK0831797T3 (de)
ES (1) ES2283002T3 (de)
GB (1) GB2301775B (de)
NZ (1) NZ309130A (de)
WO (1) WO1996040092A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827652A (en) 1995-10-31 1998-10-27 Applied Food Biotechnology, Inc. Zeaxanthin formulations for human ingestion
CA2188983C (en) * 1995-10-31 2001-02-27 Kevin M. Garnett Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans
US5747544A (en) * 1995-10-31 1998-05-05 Applied Food Biotechnology, Inc. Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans
WO1997048388A1 (en) * 1996-06-17 1997-12-24 The Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
GB9704972D0 (en) * 1997-03-11 1997-04-30 Howard Foundation Flicker photometer
WO1999018814A1 (en) * 1997-10-14 1999-04-22 Quest International B.V. Preparation for the enhancement of the antioxidant status of cells
BR9908891A (pt) * 1998-03-18 2001-10-02 Kemin Ind Inc Processos para aumentar a absorção e biodisponibilidade de carotenóides em humanos e aves domésticas, para aumentar a deposição dos carotenóides nos tecidos e gemas de ovo de aves domésticas, e para aumentar a deposição dos carotenóides nos tecidos, incluindo o sangue e a região macular da retina, de humanos, e, suplemento de alimento para aumentar a absorção e biodisponibilidade dos carotenóides em humanos e aves domésticas
US6191293B1 (en) * 1998-04-20 2001-02-20 Inexa, Industria Extractora C.A. Trans-xanthophyll ester concentrates of enhanced purity and methods of making same
NL1010351C2 (nl) * 1998-10-19 2001-01-08 Werklust & Beheer B V Esters van caroteno´den voor gebruik in de preventie en behandeling van oogaandoeningen.
IT1307281B1 (it) * 1999-11-25 2001-10-30 Simonelli Giuseppe Uso di ubichinone q10 per il trattamento locale e la prevenzione dipatalogie oftalmologiche secondarie alla terapia fotorefrattiva,
US7691406B2 (en) 2000-10-27 2010-04-06 ZeaVision LLC. Zeaxanthin formulations for human ingestion
DE10112067A1 (de) 2001-03-12 2002-09-19 Basf Ag Verfahren zur Herstellung von 2,7-Dimethyl-2,4,6-octarienal-monoacetalen
US6660297B2 (en) 2001-03-23 2003-12-09 Bausch & Lomb Incorporated Nutritional supplement to treat macular degeneration
JP2004532831A (ja) * 2001-03-27 2004-10-28 シー．エス． バイオサイエンス、 インコーポレイテッド 歯科用調剤
US7575766B2 (en) 2001-06-29 2009-08-18 Ball Horticultural Company Tagetes erecta with altered carotenoid compositions and ratios
US7081478B2 (en) 2001-06-29 2006-07-25 Chrysantis, Inc. Mixed zeaxanthin ester concentrate and uses thereof
US6784351B2 (en) 2001-06-29 2004-08-31 Ball Horticultural Company Targetes erecta marigolds with altered carotenoid compositions and ratios
DE10141018A1 (de) * 2001-08-22 2003-03-13 Eth Zuerich Eidgenoessische Te Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
WO2003063848A1 (en) * 2002-01-30 2003-08-07 Dsm Ip Assets B.V. Lutein/zeaxanthin for glare protection
WO2003068202A1 (en) * 2002-02-15 2003-08-21 Dsm Ip Assets B.V. Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
US7223909B2 (en) 2002-03-21 2007-05-29 Ball Horticultural 4-ketocarotenoids in flower petals
US20030228392A1 (en) * 2002-06-06 2003-12-11 Wyeth Infant formula compositions containing lutein and zeaxanthin
EP1864654A1 (de) * 2002-06-06 2007-12-12 Wyeth a Corporation of the State of Delaware Säuglingsnahrungszusammensetzungen mit Lutein und Zeaxanthin
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
US9192586B2 (en) 2003-03-10 2015-11-24 Zeavision Llc Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders
DE20300304U1 (de) * 2003-01-09 2003-04-24 Mann Gerhard Chem Pharm Fab Ocuvite Zink
DE20300305U1 (de) 2003-01-09 2003-04-24 Mann Gerhard Chem Pharm Fab Ocuvite Lutein
US7941211B2 (en) 2003-11-17 2011-05-10 Zeavision, Llc. Preloading with macular pigment to improve photodynamic treatment of retinal vascular disorders
DE20320101U1 (de) 2003-12-23 2004-04-29 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Mikronährstoffkombinationsprodukt geeignet zur ergänzenden bilanzierten Diät bei altersbedingter Makuladegeneration
US7351424B2 (en) 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
CA2587391A1 (en) * 2004-11-16 2006-05-26 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
AU2006213635B2 (en) * 2005-02-11 2010-06-17 Kalamazoo Holdings, Inc. A Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
US20070015735A1 (en) * 2005-03-23 2007-01-18 Lockwood Samuel F Water-dispersible carotenoids, including analogs and derivatives
WO2007029008A2 (en) * 2005-09-08 2007-03-15 Dsm Ip Assets B.V. Method of treatment or prevention of age-related macular degeneration
EP1920711A1 (de) * 2006-11-13 2008-05-14 DSMIP Assets B.V. Beurteilung und Verbesserung der Sehfähigkeit
WO2008118862A1 (en) 2007-03-23 2008-10-02 Cardax Pharmaceuticals, Inc. Carotenoid analogs and derivatives for the prevention of platelet aggregation
WO2011027209A1 (en) 2009-09-02 2011-03-10 Omniactive Health Technologies Ltd. A xanthophyl composition containing macular pigments and a process for its preparation
WO2011076869A1 (en) * 2009-12-22 2011-06-30 Aakerlund Hans-Erik Isolated green plant material
EP3372280B1 (de) * 2011-07-07 2020-09-16 Howard Foundation Holdings Limited Verbesserungen an oder im zusammenhang mit der sehleistung
CA2841411C (en) 2011-07-13 2017-09-12 University Of Georgia Research Foundation, Inc. Use of xanthophyll carotenoids to improve visual performance and neural efficiency
DE102017009186A1 (de) 2017-09-25 2019-03-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Lutein und -derivate enthaltende Zusammensetzung sowie Verfahren zur Herstellung
EP4254344A1 (de) 2022-03-31 2023-10-04 Imagination Technologies Limited Parallele optimierung von begrenzungsvolumenhierarchie

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2236899A1 (de) * 1972-07-27 1974-02-07 Philips Patentverwaltung Mit wasser mischbare carotinoidemulsion
CH598197A5 (de) * 1974-10-07 1978-04-28 Hoechst Ag
JPS5320036A (en) * 1976-08-04 1978-02-23 Kubota Ltd Cooler of radiator etc.
US4048203A (en) * 1976-12-06 1977-09-13 Thomas Philip Purification of lutein-fatty acid esters from plant materials
DE2923032A1 (de) * 1979-06-07 1980-12-11 Waldemar Hankin Arzneimittel auf der basis von reiher- eidotter
JPS6065033A (ja) * 1983-09-20 1985-04-13 Toshiba Corp 軽量強化材料の製造方法
JPS6157298A (ja) * 1984-08-30 1986-03-24 Nippon Kokan Kk <Nkk> 閉鎖水域の浄化装置
DE69019035T2 (de) * 1989-02-28 1995-08-31 Nisshin Flour Milling Co Stabilisierte fettlösliche Vitaminzusammensetzungen.
US5290605A (en) * 1989-06-29 1994-03-01 Niva Shapira Sun-exposure nutritional supporting composition
IL90794A (en) * 1989-06-29 1995-03-15 Shapira Niva Nutritional sun-exposure supporting composition
DK0534955T3 (da) * 1989-08-30 1997-10-13 Applied Food Biotech Inc Fremgangsmåde til fremstilling af en zeaxanthinholdig sammensætning under anvendelse af en mikroorganisme af arten Flavobacterium multivorum.
GB9105420D0 (en) * 1991-03-14 1991-05-01 Ici Plc Expression of genes in transgenic plants
JPH05163143A (ja) * 1991-12-16 1993-06-29 Nisshin Flour Milling Co Ltd α−トコフェロールビタミンＡ酸エステル含有油性組成物
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene
JPH05320036A (ja) * 1992-05-19 1993-12-03 Shiseido Co Ltd 一重項酸素除去組成物
JPH0665033A (ja) * 1992-08-11 1994-03-08 Lion Corp 口腔用組成物
JPH06157298A (ja) * 1992-11-26 1994-06-03 Otsuka Pharmaceut Co Ltd 注射用脂肪乳剤
GB2274235B (en) * 1993-01-13 1996-06-26 Neo Life Company Of America Carotenoid food supplement
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
US5382714A (en) * 1994-03-17 1995-01-17 The Catholic University Of America Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof
WO1996019215A1 (en) * 1994-12-22 1996-06-27 Henkel Corporation Compositions of tocopherol and beta-carotene
DE59606928D1 (de) * 1995-03-10 2001-06-28 Inventio Ag Einrichtung und Verfahren zur Schwingungsdämpfung an einer Aufzugskabine

Also Published As

Publication number Publication date
AU719671B2 (en) 2000-05-18
GB9611967D0 (en) 1996-08-07
AU5907896A (en) 1996-12-30
EP0831797A1 (de) 1998-04-01
CA2224217C (en) 2010-04-13
ATE355832T1 (de) 2007-03-15
ES2283002T3 (es) 2007-10-16
WO1996040092A1 (en) 1996-12-19
NZ309130A (en) 2001-06-29
DE69636951T2 (de) 2007-11-22
GB2301775B (en) 1999-08-04
CA2224217A1 (en) 1996-12-19
DE69636951D1 (de) 2007-04-19
GB2301775A (en) 1996-12-18
EP0831797B1 (de) 2007-03-07

Similar Documents

Publication Publication Date Title
ATE355832T1 (de) Pharmazeutisch aktive karotenoide
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
ES2126536B1 (es) &#34;preparado farmaceutico para administracion intranasal y procedimientopara su produccion&#34;.
WO2005110375A8 (en) Nutritional supplement for treatment of ocular diseases
HUP9902012A2 (hu) Porfirinszármazékok alkalmazása látásjavító gyógyszerkészítmények előállítására
DK1011653T3 (da) Anvendelse af xanthophyller i medikamenter til forbedring af varigheden af muskelfunktion eller behandling af muskelforstyrrelser eller -lidelser
AR036448A1 (es) Composiciones farmaceuticas de conjugados droga insulina-oligomeros, y metodos para tratar las enfermedades con los mismos
ES2062392T3 (es) Medicamentos que comprenden salmeterol y fluticasona.
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
UY26372A1 (es) &#34;imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen &#34;
BR9811086A (pt) Utilização de preparados de eritropoietina e ferro, processo para a produção de um preparado de combinação farmacêutica e embalagem unitária farmacêutica
AR017877A1 (es) Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo
CN102657866A (zh) 防癌抗癌胶囊
RU2004114283A (ru) Каротиноидная композиция и способ защиты кожи
RU2003122060A (ru) Каротиноиды в качестве антигипертензивных агентов
KR20050043784A (ko) 세포의 활성을 감소시키기 위한 방법 및 약학적 제조물
ES2059312T3 (es) Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
BR9908891A (pt) Processos para aumentar a absorção e biodisponibilidade de carotenóides em humanos e aves domésticas, para aumentar a deposição dos carotenóides nos tecidos e gemas de ovo de aves domésticas, e para aumentar a deposição dos carotenóides nos tecidos, incluindo o sangue e a região macular da retina, de humanos, e, suplemento de alimento para aumentar a absorção e biodisponibilidade dos carotenóides em humanos e aves domésticas
UY25510A1 (es) Procedimiento para la producción de preparados efervescentes
NO20011667L (no) Behandling av dyspepsi
US10299503B2 (en) N-acetyl cysteine based compositions
WO2002041897A3 (fr) Compositions pharmaceutiques a action antidiabetique constitues de l&#39;association d&#39;un biguanide et d&#39;un sulfonamide
CA2018227A1 (en) Association of physiologically dosed vitamin a and of various active principles having a therapeutical activity
RU2005128412A (ru) Способ профилактики и лечения задержаний последов и эндометритов у животных, например у коров, пенообразующими препаратами
IT8448710A1 (it) Riduzione degli effetti tossici causati da farmaci antrachinonici